SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial

NCT00418938 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Colon Cancer
Colorectal Cancer
Metastatic Cancer
Rectal Cancer
Metastatic Colorectal Cancer

Interventions

DRUG: Panitumumab
DRUG: Bevacizumab
DRUG: Leucovorin
DRUG: Irinotecan
DRUG: 5-Fluorouracil

Sponsor

Amgen